Dayanithi Govindan


Research Director CNRS

Contact: govindan.dayanithi(at)

Phone : 04 67 14 93 47

Group 1: Metabolic impacts in tauopathies

Delprat Benjamin


Research Fellow CNRS

Contact: benjamin.delprat(at)

Phone: + 33/04 67 14 36 23

Group 2: Cellular determinants of neuroprotection


Desrumaux Catherine

silhouette f

Research Fellow Inserm

Contact: catherine.desrumaux-piazza(at)

Phone: 04 67 14 36 89

Group 4: Environmental impact in Alzheimer’s disease

Freyssin Aline


Chef de projet Rest

Contact : a.freyssin(at)

Téléphone : 0467144626

Group 2: Cellular determinants of neuroprotection

Givalois Laurent


Research Fellow CNRS

Associate Professor at the Laval University of Québec city

Contact: laurent.givalois(at)

Phone: 04 67 14 38 14

Group 4: Environmental impact in Alzheimer’s disease

Lievens Jean-Charles


Research Fellow CNRS

Contact: jean-charles.lievens(at)

Phone: 04 67 14 32 85

Group 2: Cellular determinants of neuroprotection



Lonjon Nicolas



Contact: n-lonjon(at)

Group 3: Integrative biology of neuroregeneration

Maurice Tangui


Research Director CNRS

Contact: tangui.maurice(at)

Phone: + 33/04 67 14 36 23

Group 2: Cellular determinants of neuroprotection

NATIONAL Collaborations

  • CNRS UMR 5088, Laboratoire d'Innovation Thérapeutique, Toulouse
  • CNRS UMR 7200, Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Strasbourg
  • CNRS UMR 5253, Ecole Nationale Supérieure de Chimie, Montpellier
  • INRA UMR 866, Dynamique Musculaire et Métabolisme, Montpellier
  • INSERM U 1051, Institut des Neurosciences de Montpellier, Montpellier
  • INSERM U 1191, Institut de Génomique Fonctionnelle, Montpellier
  • Société d'Accélération de Transfert de Technologie AxLR, Montpellier

INTERNATIONAL Collaborations

  • Department of Histology, Faculty of Medical Sciences, Havana, Cuba
  • Institute of Chemical Biology, Ilia State University, Tbilisi, Georgia
  • Anavex Life Sciences, New York, USA


Tangui has spent more than 25 years in the field of neurosciences, including behavioral and molecular neuropharmacology, sigma receptors, neuropeptides, neurosteroids, neurotrophic factors, drug addiction, normal/pathological aging models including Alzheimer’s and related disorders, and behavioral phenotyping of rodent models. His publication records include 125 scientifc articles, 210 communications at national or international meeting, 5 patents and 35 invited conferences.

Tangui is CNRS Research Director since ten years and held research positions at Institut National de La Santé et de la Recherche Médicale (INSERM) U336, U710, U1198 and Centre National de la Recherche Scientifique (CNRS) UMR5102 in Montpellier. Tangui is a Chemical Engineer from ENSCM, by training. He holds a Ph.D. In cellular and molecular biology with a speciality in neuropharmacology from the university of Montpellier in 1990 and spent two years as a post-doc fellow in the Jouveinal Research Institute (Fresnes, France) and the Departments of Neuropsychopharmacology at Nagoya University Hospital and of Chemical Pharmacology at Meijo University (Nagoya, Japan). Tangui initiated the creation of a CRO company, Amylgen, and has several collaborations with industry, through regular contracts or scientific advisory boards. He was recipient of the bronze medal from CNRS.

Robine Jean-Marie

robine Demographer, Research Director Inserm, and Professor at EPHE
Cermes3 et MMDN (U1198), Associate Researcher, Ined (MSE)

Contact: jean-marie.robine(at)

Phone: 04 67 14 33 85

Group 1: Metabolic impacts in tauopathies


Jean-Marie Robine is a Research Director at Inserm, the French National Institute of Health and Medical Research (, within the Cermes3 Research group in Paris and the Unit 710 in Montpellier ( where he heads the research team Biodemography of longevity and vitality. He is also a Study Director at the advanced school Ecole pratique des hautes études ( in Paris. He studies human longevity, with the aim of understanding the relations between health and longevity. In particular, he measures the impact that the increase in adult life durations may have on the health status of the elderly population.

Since its creation in 1989, he has been the coordinator of the International Network on Health Expectancy (REVES), which brings together more some 100 researchers worldwide ( He is the project leader of the Joint Action European Life and Health Expectancy Information System (, which provides analysis of disability-free life expectancies in the European Union (Healthy Life Years-HLY). He is co-responsible for the development of the International Database on Longevity (IDL) in association with the Max Planck Institute for Demographic Research (Rostock) and Ined (Paris). He is one of the principal investigators of the Genetic of Healthy Ageing project (GEHA) and the project leader of the healthy longevity project granted by AXA Research Fund: the Five-Country Oldest Old Project (5-COOP). He is one of the Directors of the new French Research Consortium on ageing and longevity (GDR CNRS 3662, 2014-2017).